Today, Zacks Equity Research Equity Philip Morris International Inc. PM, Altria Group, Inc. MO and Turning Point Brands, ...

The agency is missing deadlines and not responding to biotech companies, forcing some to push back clinical trials.

Tobacco companies like PM, MO and TPB are investing heavily in smoke-free products to align with health trends and regulatory ...

Federal officials need to step up efforts to bar imported e-cigarettes that target youth with sweet flavors, a coalition of ...

A three-judge panel wrestled Thursday with Novartis AG’s challenge against the FDA over its approval of a generic version of ...

Yuflyma is a high-concentration and citrate-free formulation of Humira biosimilar, approved for multiple inflammatory ...

The Office on Smoking and Health at the CDC is no more, putting state quitlines and national data on youth tobacco use at ...

The nonprofit Physicians Committee for Responsible Medicine, which promotes the use of human-relevant test methods to replace ...

Triple Canopy has secured a task order valued at $95 million to provide Protective Security Officers, supervisors and ...

The US Food and Drug Administration (FDA) has accepted Regeneron Pharmaceuticals’ supplemental biologics licence application ...